文献速递心力衰竭与心肌病

心力衰竭进展中蛋白磷酸酶1相互作用组的重排

Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.
PubMed 文献 · Circulation · 2018-01-01

本研究对横向主动脉缩窄小鼠按射血分数分组,用抗PP1c抗体亲和纯化联合高分辨质谱定义心脏PP1相互作用组。

要点

  • 9个PP1c相互作用蛋白的结合变化与心衰进展强相关,包括2个已知和7个新蛋白。
  • Ppp1r7与PP1c结合最强,心脏特异性敲低导致心功能障碍和钙释放受损。

核心结论

  • PP1应在其相互作用组层面研究,该组在心衰进展中发生显著重排。
  • 与心衰进展相关的9个关键相互作用蛋白可能是心衰治疗的潜在靶点。
  • Ppp1r7可能通过作为PP1c的竞争性分子「海绵」在调控PP1相互作用组中发挥核心作用。

研究设计与样本

  • 小鼠行横向主动脉缩窄,按射血分数分为假手术、肥厚、中度心衰(射血分数30%-40%)和重度心衰(射血分数<30%)组。
  • 心脏裂解物用抗PP1c抗体进行亲和纯化,随后行高分辨质谱。
  • 在小鼠心肌细胞和HeLa细胞中分别用腺相关病毒血清型9和siRNA敲低Ppp1r7,并对分离的心室肌细胞行钙成像。

主要发现

  • 该数据集为迄今从任何组织捕获的最大可重复PP1相互作用组,包括原发和二级/三级相互作用蛋白。
  • 9个PP1c相互作用蛋白的结合变化与心衰进展强相关,包括2个已知(Ppp1r7和Ppp1r18)和7个新相互作用蛋白。
  • 在整个心脏PP1相互作用组中,Ppp1r7与PP1c的结合最高。
  • 小鼠心脏特异性敲低Ppp1r7导致心功能障碍和肌浆网钙释放中断。

临床怎么用

  • PP1相关心衰研究应关注其相互作用组而非仅催化亚基。
  • Ppp1r7及另外8个心衰进展相关相互作用蛋白可作为潜在治疗靶点进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF) is a complex disease with a rising prevalence despite advances in treatment. Protein phosphatase 1 (PP1) has long been implicated in HF pathogenesis, but its exact role is both unclear and controversial. Most previous studies measured only the PP1 catalytic subunit (PP1c) without investigating its diverse set of interactors, which confer localization and substrate specificity to the holoenzyme. In this study, we define the PP1 interactome in cardiac tissue and test the hypothesis that this interactome becomes rearranged during HF progression at the level of specific PP1c interactors. METHODS: Mice were subjected to transverse aortic constriction and grouped on the basis of ejection fraction into sham, hypertrophy, moderate HF (ejection fraction, 30%-40%), and severe HF (ejection fraction <30%). Cardiac lysates were subjected to affinity purification with anti-PP1c antibodies followed by high-resolution mass spectrometry. PP1 regulatory subunit 7 (Ppp1r7) was knocked down in mouse cardiomyocytes and HeLa cells with adeno-associated virus serotype 9 and siRNA, respectively. Calcium imaging was performed on isolated ventricular myocytes. RESULTS: Seventy-one and 98 PP1c interactors were quantified from mouse cardiac and HeLa lysates, respectively, including many novel interactors and protein complexes. This represents the largest reproducible PP1 interactome data set ever captured from any tissue, including both primary and secondary/tertiary interactors. Nine PP1c interactors with changes in their binding to PP1c were strongly associated with HF progression, including 2 known (Ppp1r7 and Ppp1r18) and 7 novel interactors. Within the entire cardiac PP1 interactome, Ppp1r7 had the highest binding to PP1c. Cardiac-specific knockdown in mice led to cardiac dysfunction and disruption of calcium release from the sarcoplasmic reticulum. CONCLUSIONS: PP1 is best studied at the level of its interactome, which undergoes significant rearrangement during HF progression. The 9 key interactors that are associated with HF progression may represent potential targets in HF therapy. In particular, Ppp1r7 may play a central role in regulating the PP1 interactome by acting as a competitive molecular "sponge" of PP1c.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Chiang DY, Alsina KM, Corradini E, et al. Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. Circulation. 2018. PMID: 29669786. doi:10.1161/CIRCULATIONAHA.118.034361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。